Why the study?
Does intensive antihypertensive therapy (target systolic BP < 120 mm Hg) reduce major cardiovascular events compared to standard therapy in high-risk patients?
Population
High-risk patients with hypertension, diabetes, or chronic renal disease
Comparison
Intensive antihypertensive therapy aimed at… vs Standard antihypertensive therapy
Design
Review
Authors
Loading...
May warrant caution with systolic BP targets <120 mm Hg in high-risk patients; leaves optimal targets unresolved pending dedicated trials.
Does intensive antihypertensive therapy (target systolic BP < 120 mm Hg) reduce major cardiovascular events compared to standard therapy in high-risk patients?
Aggressive blood pressure lowering below 120 mm Hg in high-risk patients may increase the risk of coronary events, suggesting caution and revitalizing the J-curve concept.
Volpe et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: